nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.0444	0.0479	CbGpPWpGaD
Salmeterol—Labetalol—CYP2D6—endogenous depression	0.0405	0.567	CrCbGaD
Salmeterol—CYP2C8—CYP2E1 reactions—CYP2D6—endogenous depression	0.0379	0.0409	CbGpPWpGaD
Salmeterol—CYP3A7—Xenobiotics—CYP2D6—endogenous depression	0.0376	0.0404	CbGpPWpGaD
Salmeterol—Propafenone—CYP2D6—endogenous depression	0.031	0.433	CrCbGaD
Salmeterol—CYP3A5—Xenobiotics—CYP2D6—endogenous depression	0.0271	0.0292	CbGpPWpGaD
Salmeterol—ADRB2—Monoamine GPCRs—HTR1A—endogenous depression	0.0267	0.0288	CbGpPWpGaD
Salmeterol—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.0263	0.0283	CbGpPWpGaD
Salmeterol—CYP3A5—Tamoxifen metabolism—CYP2D6—endogenous depression	0.0261	0.0281	CbGpPWpGaD
Salmeterol—ADRB2—Monoamine GPCRs—HTR2C—endogenous depression	0.0258	0.0278	CbGpPWpGaD
Salmeterol—CYP2C8—Xenobiotics—CYP2D6—endogenous depression	0.0235	0.0253	CbGpPWpGaD
Salmeterol—ADRB2—Monoamine GPCRs—HTR7—endogenous depression	0.0226	0.0244	CbGpPWpGaD
Salmeterol—CYP2C8—Tamoxifen metabolism—CYP2D6—endogenous depression	0.0226	0.0244	CbGpPWpGaD
Salmeterol—ADRB2—Amine ligand-binding receptors—HTR1A—endogenous depression	0.0225	0.0242	CbGpPWpGaD
Salmeterol—ADRB2—Amine ligand-binding receptors—HTR2C—endogenous depression	0.0217	0.0234	CbGpPWpGaD
Salmeterol—ADRB2—Amine ligand-binding receptors—HTR7—endogenous depression	0.019	0.0205	CbGpPWpGaD
Salmeterol—ADRB2—Monoamine GPCRs—HTR2A—endogenous depression	0.0158	0.0171	CbGpPWpGaD
Salmeterol—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.0156	0.0168	CbGpPWpGaD
Salmeterol—CYP3A7—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.0154	0.0166	CbGpPWpGaD
Salmeterol—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.0151	0.0163	CbGpPWpGaD
Salmeterol—ADRB2—Amine ligand-binding receptors—HTR2A—endogenous depression	0.0133	0.0143	CbGpPWpGaD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.0126	0.0136	CbGpPWpGaD
Salmeterol—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.0126	0.0136	CbGpPWpGaD
Salmeterol—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.0121	0.0131	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—ADM—endogenous depression	0.0115	0.0124	CbGpPWpGaD
Salmeterol—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.0113	0.0121	CbGpPWpGaD
Salmeterol—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.0111	0.012	CbGpPWpGaD
Salmeterol—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.0107	0.0115	CbGpPWpGaD
Salmeterol—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.0104	0.0112	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Other—HTR7—endogenous depression	0.01	0.0108	CbGpPWpGaD
Salmeterol—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00976	0.0105	CbGpPWpGaD
Salmeterol—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00964	0.0104	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—CRH—endogenous depression	0.00963	0.0104	CbGpPWpGaD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00951	0.0102	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00914	0.00984	CbGpPWpGaD
Salmeterol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—endogenous depression	0.00885	0.00953	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00792	0.00853	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—HTR7—endogenous depression	0.00784	0.00845	CbGpPWpGaD
Salmeterol—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00764	0.00823	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Other—HTR2A—endogenous depression	0.00704	0.00758	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00688	0.00741	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—CYP2D6—endogenous depression	0.00672	0.00723	CbGpPWpGaD
Salmeterol—CYP3A7—Metapathway biotransformation—CYP2D6—endogenous depression	0.00662	0.00713	CbGpPWpGaD
Salmeterol—CYP3A7—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00619	0.00667	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00596	0.00642	CbGpPWpGaD
Salmeterol—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00552	0.00595	CbGpPWpGaD
Salmeterol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00524	0.00564	CbGpPWpGaD
Salmeterol—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00517	0.00557	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.00516	0.00556	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—COMT—endogenous depression	0.00509	0.00548	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—MAOA—endogenous depression	0.00505	0.00544	CbGpPWpGaD
Salmeterol—CYP3A7—Metapathway biotransformation—COMT—endogenous depression	0.00502	0.00541	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.00498	0.00537	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—CYP2D6—endogenous depression	0.00485	0.00523	CbGpPWpGaD
Salmeterol—CYP3A5—Metapathway biotransformation—CYP2D6—endogenous depression	0.00479	0.00516	CbGpPWpGaD
Salmeterol—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00478	0.00515	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.00459	0.00495	CbGpPWpGaD
Salmeterol—CYP3A5—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00448	0.00482	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.00442	0.00476	CbGpPWpGaD
Salmeterol—ADRB2—G alpha (s) signalling events—POMC—endogenous depression	0.00439	0.00473	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00436	0.0047	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00427	0.0046	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00425	0.00458	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—CYP2D6—endogenous depression	0.0042	0.00453	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—ADM—endogenous depression	0.00417	0.00449	CbGpPWpGaD
Salmeterol—CYP2C8—Metapathway biotransformation—CYP2D6—endogenous depression	0.00415	0.00447	CbGpPWpGaD
Salmeterol—CYP2C8—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00388	0.00418	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00374	0.00403	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—COMT—endogenous depression	0.00368	0.00396	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—MAOA—endogenous depression	0.00365	0.00393	CbGpPWpGaD
Salmeterol—CYP3A5—Metapathway biotransformation—COMT—endogenous depression	0.00363	0.00391	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CRH—endogenous depression	0.0035	0.00377	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—OXT—endogenous depression	0.0035	0.00377	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR1A—endogenous depression	0.00337	0.00363	CbGpPWpGaD
Salmeterol—CYP3A7—Biological oxidations—POMC—endogenous depression	0.00329	0.00354	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR2C—endogenous depression	0.00325	0.0035	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.0032	0.00344	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—COMT—endogenous depression	0.00319	0.00343	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—MAOA—endogenous depression	0.00316	0.00341	CbGpPWpGaD
Salmeterol—CYP2C8—Metapathway biotransformation—COMT—endogenous depression	0.00314	0.00338	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.00306	0.00329	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR7—endogenous depression	0.00285	0.00307	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00262	0.00282	CbGpPWpGaD
Salmeterol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00257	0.00277	CbGpPWpGaD
Salmeterol—CYP3A5—Biological oxidations—POMC—endogenous depression	0.00238	0.00256	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—ADM—endogenous depression	0.00236	0.00254	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.00226	0.00243	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.00223	0.0024	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—ADM—endogenous depression	0.00214	0.00231	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00209	0.00225	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00208	0.00224	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—POMC—endogenous depression	0.00206	0.00222	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR2A—endogenous depression	0.00199	0.00215	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CRH—endogenous depression	0.00198	0.00213	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—OXT—endogenous depression	0.00198	0.00213	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR1A—endogenous depression	0.0019	0.00205	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TPH1—endogenous depression	0.0019	0.00204	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2C—endogenous depression	0.00184	0.00198	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OXT—endogenous depression	0.00179	0.00193	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CRH—endogenous depression	0.00179	0.00193	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR1A—endogenous depression	0.00173	0.00186	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—COMT—endogenous depression	0.00171	0.00184	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—MAOA—endogenous depression	0.0017	0.00183	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	0.00169	0.00182	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2C—endogenous depression	0.00167	0.0018	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR7—endogenous depression	0.00161	0.00173	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—POMC—endogenous depression	0.00159	0.00172	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR7—endogenous depression	0.00146	0.00157	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TPH2—endogenous depression	0.00144	0.00155	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CACNB2—endogenous depression	0.00144	0.00155	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—DPYD—endogenous depression	0.00141	0.00152	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—WASF2—endogenous depression	0.00138	0.00149	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TPH1—endogenous depression	0.00137	0.00148	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—WASF1—endogenous depression	0.00133	0.00143	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CACNA1C—endogenous depression	0.00131	0.00142	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ADM—endogenous depression	0.00127	0.00136	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TPH1—endogenous depression	0.00119	0.00128	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP2D6—endogenous depression	0.00115	0.00124	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2A—endogenous depression	0.00113	0.00121	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—POMC—endogenous depression	0.00111	0.00119	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CRH—endogenous depression	0.00106	0.00114	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OXT—endogenous depression	0.00106	0.00114	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TPH2—endogenous depression	0.00104	0.00112	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CACNB2—endogenous depression	0.00104	0.00112	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2A—endogenous depression	0.00102	0.0011	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DPYD—endogenous depression	0.00102	0.0011	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR1A—endogenous depression	0.00102	0.0011	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2C—endogenous depression	0.000986	0.00106	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CACNA1C—endogenous depression	0.00095	0.00102	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—POMC—endogenous depression	0.0009	0.00097	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TPH2—endogenous depression	0.000899	0.000969	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CACNB2—endogenous depression	0.000899	0.000969	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DPYD—endogenous depression	0.000885	0.000953	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—COMT—endogenous depression	0.00087	0.000937	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MAOA—endogenous depression	0.000864	0.000931	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR7—endogenous depression	0.000863	0.00093	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP2D6—endogenous depression	0.00083	0.000894	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CACNA1C—endogenous depression	0.000823	0.000886	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—POMC—endogenous depression	0.000817	0.00088	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000791	0.000852	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2D6—endogenous depression	0.000719	0.000774	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TPH1—endogenous depression	0.000637	0.000686	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—COMT—endogenous depression	0.000629	0.000678	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MAOA—endogenous depression	0.000625	0.000673	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2A—endogenous depression	0.000605	0.000651	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—POMC—endogenous depression	0.000563	0.000606	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—COMT—endogenous depression	0.000545	0.000587	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MAOA—endogenous depression	0.000541	0.000583	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—POMC—endogenous depression	0.000483	0.00052	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TPH2—endogenous depression	0.000483	0.00052	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CACNB2—endogenous depression	0.000483	0.00052	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DPYD—endogenous depression	0.000475	0.000512	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CACNA1C—endogenous depression	0.000442	0.000476	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—POMC—endogenous depression	0.000407	0.000438	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2D6—endogenous depression	0.000386	0.000416	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—POMC—endogenous depression	0.000352	0.000379	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—COMT—endogenous depression	0.000292	0.000315	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MAOA—endogenous depression	0.00029	0.000313	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—POMC—endogenous depression	0.000189	0.000204	CbGpPWpGaD
